CLINICAL_TRIALS
trial_result
· 2013-12-16
Clinical Trial Update: Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma [Phase 2]
Summary
A Phase 2 clinical trial evaluating azacitidine for relapsed or refractory multiple myeloma has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayside Health | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED